Global Peptide Therapeutics Market 2016-2020

SKU ID : TNV- 10278517

Publishing Date : 04-Mar-2016

No. of pages : 81

PRICE
2500
4000

  • About Peptide Therapeutics

    Peptides are organic compounds that are composed of amino acids linked chemically by peptide bonds. They are the most potent biologically active substances found in nature and are used to trigger, control, and maintain an individual's physiological processes. However, using peptides as therapeutic agents was always difficult as they are quite instable and cannot pass through cellular membranes. They also require a specific technology to tackle extensive and challenging steps in their synthesis. Over 80 peptides are marketed by companies that explore the probabilities of designing and engineering peptides that can overcome their natural limits. They can be introduced as a treatment for chronic indications.

    Technavio’s analysts forecast the global peptide therapeutics market to grow at a CAGR of 7.92% during the period 2016-2020.

    Covered in this report
    The report covers the present scenario and the growth prospects of the global peptide therapeutics market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of prescription and generic drugs used to treat diseases.

    The market is divided into the following segments based on geography:
    • Americas
    • APAC
    • EMEA

    Technavio's report, Global Peptide Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

    Key vendors
    • Eli Lilly
    • Novo Nordisk
    • Sanofi
    • Takeda Pharmaceutical
    • Teva Pharmaceuticals

    Other prominent vendors
    • AbbVie
    • Advanced Accelerator Applications
    • Akashi Therapeutics
    • Amgen
    • Anthera Pharmaceuticals
    • AstraZeneca
    • Bachem
    • Bristol-Myers Squibb
    • Cardiorentis
    • Corden Pharma International
    • Debiopharm
    • Derma Sciences
    • GlaxoSmithKline
    • Hanmi Pharmaceutical
    • Insmed
    • Ipsen
    • Johnson & Johnson
    • Lonza
    • Mallinckrodt
    • MolMed
    • Merck
    • Novartis
    • Nymox Pharmaceutical
    • Par Pharmaceuticals
    • PeptiDream
    • Polypeptide Group
    • Radius Health
    • Repligen
    • Roche
    • SciClone
    • Shire
    • The Medicines Company
    • Transition Therapeutics
    • X-Gen Pharmaceuticals
    • Zealand Pharma
    • Zydus Cadila

    Market driver
    • Increase in patient population
    • For a full, detailed list, view our report

    Market challenge
    • High cost of therapy
    • For a full, detailed list, view our report

    Market trend
    • Shifting focus toward untapped markets
    • For a full, detailed list, view our report

    Key questions answered in this report
    • What will the market size be in 2020 and what will the growth rate be?
    • What are the key market trends?
    • What is driving this market?
    • What are the challenges to market growth?
    • Who are the key vendors in this market space?
    • What are the market opportunities and threats faced by the key vendors?
    • What are the strengths and weaknesses of the key vendors?

    You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports